Kymera Therapeutics (KYMR) Q1 2025 Earnings

Feb 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.88
-0.78
-0.68
-0.58

Details

Expected EPS
-0.774769
Actual EPS
-0.88
Surprise EPS
-0.11
Surprise Percent
-13.58%

Description

⁨Kymera Therapeutics⁩ (⁦KYMR⁩) has reported earnings of ⁦-0.88⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts